Market Research Report
Global Photomedicine Market Research and Forecast 2017-2022
|Published by||Orion Market Research Pvt Ltd||Product code||599597|
Delivery time: 2-3 business days
|Global Photomedicine Market Research and Forecast 2017-2022|
|Published: November 16, 2017||Content info:||
In the forecasted period of 2017-2022, the photomedicine market is anticipated to witness an impressive growth rate. Increasing trend of cosmetic surgeries globally is a major factor driving the photomedicine market. Photomedicine includes treatment of the diseases with the application of light; Light is composed of packets of energy called photons. The light can be defined as non- ionizing electromagnetic radiation between the wavelength of 200 nm to about 10000 nm and it can produce heating, mechanical effect, and chemical reactions. This transfer of light energy with the help of photon absorption can lead to many applications in photomedicine.
Photomedicine surgeries are more accurate than other manual surgeries, therefore, it is contributing towards the growth of the market. Rising cosmetic surgeries for aesthetics, rising prevalence's of skin diseases, increasing eye diseases and its treatment through laser are some of the major factor driving the market growth. However, available alternative treatment and safety concerns could restrain the growth of the photomedicine market.
The market of the Photomedicine can be segmented on the basis of Technology and application. On the basis of technology, the market is further segmented in Laser, Bioptron light therapy, full-spectrum light, diachronic lamps, light emitting diodes & fluorescent lamps segments. Based on applications the market is segmented in dermatology, ophthalmology, dentistry, oncology and wound healing segment.
Based on geography the market is segmented Europe, North America, Asia Pacific and Rest of the World (Row) regions. In the current scenario, North America dominates the global photomedicine market. According to the American Society of Plastic Surgeons, more than 15.9 million surgical and minimally-invasive cosmetic procedures were performed in 2015. The well-established healthcare infrastructure, technology and innovations, reimbursement policy, funding and government subsidies are major driving factors in the region.
The report includes a detailed market overview, market determinants, company profiling, market segmentation, geographical analysis, strategic recommendations, key company analysis, key findings, market estimations, market insights, analyst insights and predictive analysis of the market.
Key players of photomedicine market includes Abbott Laboratories Ltd., Alma Lasers Ltd., Angiodynamics, Inc., Biolase Technology Inc., Biolitec Ag, Bright Photomedicine, Colorado Skin And Vein, Koninklijke Philips N.V., Lumenis Ltd., Novartis AG, Pfizer Inc., Photomedex, Inc., Quantel Medical Sas, SpectraneticsCorp, Switch Biotech LLC, Syneron Medical Ltd., Thor Photomedicine Ltd., Vascular Solutions, Vein And Alma Lasers Ltd. The market players are adopting the strategy of collaboration with universities and research institutes that work on grafting and organ regeneration technologies. The leading companies are expanding their business by acquisition for example, Koninklijke Philips N.V. has announced to acquire Syneron Medical Ltd. in $1.7 billion in June 2017.
The report covers: